tirzepatide mash nash phase 3 Incretin-based therapy for MASH: are two better than one? Tirzepatide Found Superior to Placebo – Nearly 62% achieve MASH resolution

This was seen in association with increased baseline and post-prandial intact GLP-1 concentrations, reduced post-prandial glucagon levels and sustained insulin levels, which in the presence of lower glucose levels resulted in an increase of insulinogenic index as a sign of stimulated beta-cell function, which provided a first insight into the mechanism of action of DPP-4 inhibition in type 2 diabetes (Figure 4)

Yan H, Hao L, Chen H, Zhou X, Ji H, Zhou H

If travelling to remote areas where proper disposal facilities are unavailable, transport used sharps home in your secure container according to your airline's policy

Your physician designs your stack based on goals and labs